NEWS ROOM
- 2024.04.01Axcelead DDP Change of Representative Director Press Release
- 2024.04.01Notice of Changes in Representative Director Press Release
- 2024.02.26PassPort Technologies, Inc. Initiated US Phase I Clinical Trial of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine Press Release
- 2024.02.13Teijin and Axcelead to Determine the Name of Drug Discovery Research JV Press Release
- 2023.12.18Axcelead’s Presentation Date and Time at the 42nd Annual JP Morgan Healthcare Conference Topics